|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
2/6/08 Debrabandere Lode 4 Officer² 1:4K Osiris Therapeutics, Inc. Section16 Direct/FA
2/6/08 Williams Michelle LeRoux 4 Officer² 1:5K Osiris Therapeutics, Inc. Section16 Direct/FA
2/6/08 Fender Earl R 4 Officer² 1:4K Osiris Therapeutics, Inc. Section16 Direct/FA
2/6/08 Carmitchel Harry E 4 Officer² 1:5K Osiris Therapeutics, Inc. Section16 Direct/FA
2/6/08 Mills C Randal 4 Dir.,Off.² 1:4K Osiris Therapeutics, Inc. Section16 Direct/FA
2/6/08 Moyes Jay M 4 Director² 1:4K Osiris Therapeutics, Inc. Section16 Direct/FA
2/6/08 Barnhill Gregory Hurd 4 Director² 1:4K Osiris Therapeutics, Inc. Section16 Direct/FA
2/6/08 Gutzwiller Felix 4 Director² 1:4K Osiris Therapeutics, Inc. Section16 Direct/FA
2/6/08 Friedli Peter 4 D,%Own,Oth² 1:7K Osiris Therapeutics, Inc. Section16 Direct/FA
____________ | ¹ | Filing/Form Type: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|